Veradigm RxTruePrice™ Users See Positive Impact on Medication Affordability

Blog Posts  |  08 April 2019  |  By Tom Pasquariello, PharmD, BCPS, BCMAS, PMSP

At Veradigm®, we are working every day to transform health insightfully. What does that mean?

It’s about bringing people and information together in new, efficient, and meaningful ways to provide fresh perspectives. Our objective is to add value across the healthcare ecosystem - from BioPharma to Health Information Technology companies to Health Plans and most importantly to the patients and providers they serve.

Addressing medication affordability through the Veradigm RxTruePrice™ prescription price transparency solution is an example of how Veradigm is working to make this transformation a reality. By delivering patient-specific data on discounted pharmacy benefit pricing including cash, therapeutic alternatives and competitive prices at local pharmacies directly into each prescriber’s clinical workflow, we empower providers to change the patient conversation at the point of care.

With 29% of patients not taking their medications as prescribed, in the past 12 months due to cost, it has never been more important to consider the patient’s financial perspective when determining a care plan including medications.

To this point, there has been relatively little data published on the early observed impact of prescription price transparency technologies for patients and providers. Veradigm is pleased to be a key contributor to the ongoing conversation about medication affordability with the following report, which includes recently published results on the impact health care providers and their patients are seeing from the use of Veradigm RxTruePrice™.

Click below to download report on observed impact of price transparency technology on patients and providers.

Read Price Transparency Technology Report